key: cord-0823014-133u377v
authors: Li, Jingwen; Long, Xi; Zhu, Chunli; Wang, Hengmin; Wang, Tao; Lin, Zhicheng; Li, Jinghong; Xiong, Nian
title: Olfactory dysfunction in recovered COVID‐19 patients
date: 2020-05-28
journal: Mov Disord
DOI: 10.1002/mds.28172
sha: 1b3b1abb426dbd8d915417a61119137fecd9314d
doc_id: 823014
cord_uid: 133u377v

nan

It has been reported that loss of smell could be an early sign of SARS-CoV-2 infection, even before other typical symptoms such as cough, fever, shortness of breath for COVID-19 patients 1 . Dysosmia was identified in 5.1% of the COVID-19 patients in Wuhan, China 2 . Previous studies have shown that the olfactory dysfunction could be resolved within 2 -4 weeks in the majority of COVID-19 patients 1, 3 . It remains unclear with the duration of olfactory dysfunction and the long-term effects of persistent olfactory dysfunction in COVID-19 patients. The persistent dysosmia not only has a negative impact on patients' quality of life, but also may indicate an early symptom of neurodegenerative disease such as Parkinson's disease 4 .

Here we present a multi-center prospective cohort study for long-term follow up of COVID-19 patients with dysosmia. We compared 145 COVID-19 patients with dysosmia with 170 healthy subjects to investigate the frequency and duration of dysosmia. All subjects completed the smell identification testing by using T&T scores system, with odors generally familiar to the Chinese population, as an auxiliary diagnosis of dysosmia 5 .

We find for the first time that dysosmia may last up to 95 days or longer (median duration 62 days) in COVID-19 patients. Among all the patients, after 25 days from onset of symptom, 11% of patients (16 of 145) still had dysosmia (P = 1.72×10 -4 ).

The duration of olfactory dysfunction is much longer compared with the European report 1 . Our results showed that 10 of 16 COVID-19 patients with dysosmia were over 60 year-old, consistent with olfactory dysfunction is more common in the elderly population.

In these two groups, 8 (6%) of COVID-19 patients and 35 (21%) of healthy subjects were smokers. 4 (50%) of the 8 COVID-19 patients with smoking history had dysosmia. COVID-19 patients with a smoking history were more likely to have long-term dysosmia (P = 5.67 x 10 -4 , Table 1 ).

As for smell identification tests, the dysosmia of garlic was in 7 (5%) of 145 COVID-19 patients versus one (1%) of 170 healthy subjects (P = 1.72 x 10 -4 ); pineapple in 13 (9%) and 1 (1%), mint in 11 (8%) and 1 (1%), ginger in 38 (26%) and 12 (7%) and the rose in 24 (16%) and 10 (6%), respectively. Post-discharge T&T scores in the patient group were significantly lower than the healthy group (P = 0.03), implying a long-term smell dysfunction in recovered COVID-19 cases.

The sample size of this study was not big enough to show any statistical Nose trauma or surgery 0(0%) 0(0%) / Rhinitis 2(10%) 0(0%)

Odors Garlic 7(5%) 1(1%)

Pineapple 13(9%) 1(1%)

Mint 11(8%) 1(1%)

Ginger 38(26%) 12(7%)

Rose 24(16%) 10(6%)

TNT score (average, range) -0.53 ± 1.10 -0.74 ± 0.65 3.42E-02

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease

Self-reported olfactory loss associates with outpatient clinical course in Covid-19

Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease

Evaluation of "Open Essence" odor-identification test card by application to healthy volunteers

Olfaction and Aging: A Mini-Review

The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system